{"id":"https://openalex.org/A5159727401","orcid":null,"observed_orcids":[],"display_name":"JL Trillo Mata","raw_author_names":["JL Trillo Mata"],"full_name":"JL Trillo Mata","works_count":3,"cited_by_count":0,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":0,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5159727401","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I2802828525","ror":"https://ror.org/0097mvx21","display_name":"Generalitat Valenciana","country_code":"ES","type":"government","lineage":["https://openalex.org/I2802828525"]},"years":[2026]},{"institution":{"id":"https://openalex.org/I4210095330","ror":"https://ror.org/00pdx2849","display_name":"Conselleria de Sanitat Universal i Salut P\u00fablica","country_code":"ES","type":"government","lineage":["https://openalex.org/I2802828525","https://openalex.org/I4210095330"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I2802828525","ror":"https://ror.org/0097mvx21","display_name":"Generalitat Valenciana","country_code":"ES","type":"government","lineage":["https://openalex.org/I2802828525"]},{"id":"https://openalex.org/I4210095330","ror":"https://ror.org/00pdx2849","display_name":"Conselleria de Sanitat Universal i Salut P\u00fablica","country_code":"ES","type":"government","lineage":["https://openalex.org/I2802828525","https://openalex.org/I4210095330"]}],"topics":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","count":3,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","count":3,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","count":1,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","count":1,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","count":1,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","value":1.21e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","value":9.6e-06,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","value":4e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","value":3.7e-06,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","value":1.9e-06,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"2780290652","wikidata":"https://www.wikidata.org/wiki/Q21011234","display_name":"Edoxaban","score":0.9757000207901001},{"id":"2780638905","wikidata":"https://www.wikidata.org/wiki/Q414462","display_name":"Apixaban","score":0.9279999732971191},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.8220000267028809},{"id":"2778661090","wikidata":"https://www.wikidata.org/wiki/Q420262","display_name":"Rivaroxaban","score":0.7148000001907349},{"id":"2779161974","wikidata":"https://www.wikidata.org/wiki/Q815819","display_name":"Atrial fibrillation","score":0.5321000218391418}],"counts_by_year":[{"year":2026,"works_count":3,"oa_works_count":3,"cited_by_count":0}],"display_name_alternatives":["JL Trillo Mata"],"block_key":"j trillo mata","works_api_url":"https://api.openalex.org/works?filter=author.id:A5159727401","updated_date":"2026-10-31T12:29:50","created_date":"2026-10-27T00:00:00"}